MedPath

A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion

Completed
Conditions
Concussion
Interventions
Device: Nautilus BrainPulse Recording
Registration Number
NCT02660164
Lead Sponsor
Jan Medical, Inc.
Brief Summary

The objective of the study is to evaluate, in a blinded fashion, the effectiveness of the Nautilus BrainPulse device when used as an aid in the diagnosis of concussion.

Detailed Description

This is a prospective, non-randomized, blinded, matched control study of young athletes (ages 10-25 years old) in competitive sports (Cohort A: higher-risk of concussion, Cohort B: lower-risk of concussion) to assess the effectiveness of the Nautilus BrainPulse device when used as an aid in the diagnosis of concussion.

The Nautilus BrainPulse is intended for use on a patient's head to non-invasively detect, amplify and capture the brain pulse, the brain motion caused by pulsatile blood flow from the cardiac cycle. The Nautilus BrainPulse analyzes the captured data to provide an aid in diagnosing an episode of concussion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
149
Inclusion Criteria
  1. Male or female subjects between 10 and 25 years of age (middle school, high school or college-age)
  2. Team member, where the team meets at least twice a week
  3. Willing and able to participate in all study evaluations and allow access to medical testing and records
  4. Signed informed consent, or have a legally authorized representative willing to provide informed consent on behalf of the subject if the subject is a minor
Exclusion Criteria
  1. Documented history of a concussion diagnosed by a physician in the last two months assessed via interview with athlete
  2. Known history of any cognitive deficits that diminish ability to administer study assessments, such as SCAT3™
  3. Wound on the head in the area of one of the Nautilus BrainPulse sensors that would impede use of the Nautilus BrainPulse device
  4. Inability to obtain a valid SCAT3 and ImPACT® baseline assessment of concussion
  5. Any serious medical, social or psychological condition that in the opinion of the investigator would impair ability to provide informed consent or otherwise disqualify a patient from participation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cohort B: Low-Risk of ConcussionNautilus BrainPulse RecordingMiddle school, high school and college athletes of either gender participating in sports where low-risk of concussion is anticipated: swimming, track, volleyball, baseball, softball and golf.
Cohort A: High-Risk of ConcussionNautilus BrainPulse RecordingMiddle school, high school and college athletes of either gender participating in sports where high-risk of concussion is anticipated: football, soccer, lacrosse, hockey, basketball, ice hockey, field hockey, rugby, cheerleading, boxing, and gymnastics.
Primary Outcome Measures
NameTimeMethod
Sensitivity and Specificity of the Nautilus Brain Pulse in detecting concussion as compared to adjudication by a panel of medical experts10 days

Sensitivity and Specificity of the Nautilus BrainPulse in detecting the number of subjects experiencing concussion as compared to the number of subjects with concussion as adjudicated by a panel of medical experts. BrainPulse measurement data will be aggregated by subject over the first 10-days of recording after the concussive event, or for subjects in the Control arm, after their selection as a control subject.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Louisiana State University

🇺🇸

Baton Rouge, Louisiana, United States

Community Hospital

🇺🇸

Munster, Indiana, United States

Meli Orthopedic Centers of Excellence

🇺🇸

Fort Lauderdale, Florida, United States

University of Wyoming

🇺🇸

Laramie, Wyoming, United States

© Copyright 2025. All Rights Reserved by MedPath